» Articles » PMID: 24185511

Somatic Mutation of CDKN1B in Small Intestine Neuroendocrine Tumors

Abstract

The diagnosed incidence of small intestine neuroendocrine tumors (SI-NETs) is increasing, and the underlying genomic mechanisms have not yet been defined. Using exome- and genome-sequence analysis of SI-NETs, we identified recurrent somatic mutations and deletions in CDKN1B, the cyclin-dependent kinase inhibitor gene, which encodes p27. We observed frameshift mutations of CDKN1B in 14 of 180 SI-NETs, and we detected hemizygous deletions encompassing CDKN1B in 7 out of 50 SI-NETs, nominating p27 as a tumor suppressor and implicating cell cycle dysregulation in the etiology of SI-NETs.

Citing Articles

Basic science and translational implications of current knowledge on neuroendocrine tumors.

Fernandez-Cuesta L, Alcala N, Mathian E, Derks J, Thirlwell C, Dayton T J Clin Invest. 2025; 135(5).

PMID: 40026252 PMC: 11870734. DOI: 10.1172/JCI186702.


p27 and Tumors: Characterization of Variants Identified in MEN4 and Breast Cancer.

Bencivenga D, Stampone E, Azhar J, Parente D, Ali W, Del Vecchio V Cells. 2025; 14(3).

PMID: 39936980 PMC: 11817124. DOI: 10.3390/cells14030188.


NET Models Meeting 2024 white paper: the current state of neuroendocrine tumour research models and our future aspirations.

Ear P, Marinoni I, Dayton T, Guenter R, Quelle D, Battistella A Endocr Oncol. 2025; 4(1):e240055.

PMID: 39822778 PMC: 11737514. DOI: 10.1530/EO-24-0055.


Case study of a neuroendocrine tumor of uncertain origin: single-cell transcriptomics unravels potential primary location.

Tatyana F, Avsievich E, Salimgereeva D, Antysheva Z, Maluchenko A, Maksimov D J Cancer Res Clin Oncol. 2024; 151(1):28.

PMID: 39738894 PMC: 11688255. DOI: 10.1007/s00432-024-06071-z.


Genetic syndromes associated with pancreatic neuroendocrine neoplasms and imaging diagnostic strategies.

Liu J, Ling J, Li L, Wu Y, Song C, Shi S Abdom Radiol (NY). 2024; .

PMID: 39694946 DOI: 10.1007/s00261-024-04764-0.


References
1.
Stephens P, Tarpey P, Davies H, Van Loo P, Greenman C, Wedge D . The landscape of cancer genes and mutational processes in breast cancer. Nature. 2012; 486(7403):400-4. PMC: 3428862. DOI: 10.1038/nature11017. View

2.
Park S, Holmes-Tisch A, Cho E, Shim Y, Kim J, Kim H . Discordance of molecular biomarkers associated with epidermal growth factor receptor pathway between primary tumors and lymph node metastasis in non-small cell lung cancer. J Thorac Oncol. 2009; 4(7):809-15. DOI: 10.1097/JTO.0b013e3181a94af4. View

3.
. Comprehensive molecular portraits of human breast tumours. Nature. 2012; 490(7418):61-70. PMC: 3465532. DOI: 10.1038/nature11412. View

4.
Sancho R, Jandke A, Davis H, Diefenbacher M, Tomlinson I, Behrens A . F-box and WD repeat domain-containing 7 regulates intestinal cell lineage commitment and is a haploinsufficient tumor suppressor. Gastroenterology. 2010; 139(3):929-41. DOI: 10.1053/j.gastro.2010.05.078. View

5.
Banerji S, Cibulskis K, Rangel-Escareno C, Brown K, Carter S, Frederick A . Sequence analysis of mutations and translocations across breast cancer subtypes. Nature. 2012; 486(7403):405-9. PMC: 4148686. DOI: 10.1038/nature11154. View